Xenical and Alli
Obesity is an epidemic in America, leading to numerous long-term health problems such as high blood pressure, diabetes, and high cholesterol. In an attempt to help those suffering from obesity, drugs have been developed that can help accelerate weight loss.
Unfortunately one of these drugs, orlistat, the main ingredient in Xenical and Alli, is now under FDA investigation for possibly causing liver damage in some users.
What are Xenical and Alli?
Approved by the FDA in 1999, orlistat is marketed under two names. Xenical, marketed by Hoffmann La Roche Ltd., is a prescription drug. In 2007, orlistat was approved for over the counter use, and is marketed over the counter as Alli by GlaxoSmithKline.
Orlistat works in the digestive system, preventing the body from absorbing about one-quarter of the fat ingested. This can lead to uncomfortable GI issues in many users, but these side effects are considered by most to be acceptable.
Serious Side Effects of Xenical and Alli
Other side effects, however, are not considered acceptable. Between 1999 and 2008, over thirty orlistat users experienced liver injury. Six of these experienced liver failure, and most were hospitalized.
Symptoms of liver failure include:
• Jaundice (yellowing of the skin and the whites of the eyes)
• Brown urine
• Stomach pain
• Overall feeling of weakness
Any of these symptoms should be reported immediately to your doctor as well as to the FDA to help establish the connection between liver failure and orlistat.
If you have experienced symptoms of liver failure while using Xenical or Alli, please contact the pharmaceutical injury attorneys at Schlichter, Bogard & Denton for more information and to schedule a free consultation. Schlichter, Bogard & Denton serves pharmaceutical injury clients nationwide.